Arnold I. Chin

Also affiliated with UCLA Health

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Tumor Heterogeneity in VHL Drives Metastasis in Clear Cell Renal Cell Carcinoma”.

Tumor Heterogeneity in VHL Drives Metastasis in Clear Cell Renal Cell Carcinoma

Research Square(2021)10.21203/rs.3.rs-846239/v1

N/A

0DataRank · unranked

1 citations

Ping Tan, Moe Ishihara, Nicholas Bayley, Shiruyeh Schokrpur, Jeremy Reynoso +9 more

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma

Signal Transduction and Targeted Therapy(2023)10.1038/s41392-023-01362-2

N/A

0DataRank · unranked

76 citations

Ping Tan, Moe Ishihara, Nicholas Bayley, Shiruyeh Schokrpur, Jeremy Reynoso +14 more

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101381

N/A

0DataRank · unranked

31 citations

Timothy Chai, Fernando Jose Garcia-Marques, Qingqing Yin, En‐Chi Hsu, Michelle Shen +25 more

Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

Cell(2025)10.1016/j.cell.2025.04.032

N/A

0DataRank · unranked

60 citations

James Elsten-Brown, Miao Li, Enbo Zhu, Zhe Li, Yuning Chen +14 more

Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial

European Urology(2025)10.1016/j.eururo.2025.09.4149

N/A

0DataRank · unranked

1 citations

Jesus E. Juarez Casillas, Paul Sargos, Tahmineh Romero Kalbasi, Sylvie Chabaud, Meryem Brihoum +22 more